Literature DB >> 14695151

Frequent loss of heterozygosity targeting the inactive X chromosome in melanoma.

James O Indsto1, Najah T Nassif, Richard F Kefford, Graham J Mann.   

Abstract

After previous preliminary observations of paradoxical deletion events affecting the inactive X chromosome in melanoma, we have surveyed the X chromosome for deletions using 23 polymorphic microsatellite markers in 28 informative (female XX) metastatic melanomas. Ten tumors (36%) showed at least one loss of heterozygosity (LOH) event, and in two cases an entire chromosome showed LOH at all informative loci. Four distinct X chromosome smallest regions of overlap can be resolved. An 18.6-Mb region on the p arm involving 9 of 28 (32%) samples lies between the markers DXS1061 and DXS1068. An equally frequently deleted smallest region of overlap straddled the centromere, bounded by DX1204 on the p arm and DXS983 14.6 Mb away in Xq11-12. One tumor potentially defines this region more tightly to a 10.6-Mb smallest region of overlap bounded by DXS1190 and DXS981 that contains the androgen receptor (AR) gene. A 6.2-Mb deleted region can be defined between the markers DXS8051 and DXS9902 in 8 of 28 (28%) tumors. An additional, less frequently deleted region of 25.7 Mb was found on distal Xq between the markers DXS1212 and DXS1193 in 5 of 28 (18%) tumors. X inactivation analysis of five tumors with LOH, using the AR exon 1 CAG repeat, showed that in each case, the inactive, hypermethylated allele was the one deleted. Analysis of copy number in this region by quantitative PCR showed restoration to disomy and, in one case, trisomy at AR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14695151

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  5 in total

Review 1.  Inactivation of X-linked tumor suppressor genes in human cancer.

Authors:  Runhua Liu; Mandy Kain; Lizhong Wang
Journal:  Future Oncol       Date:  2012-04       Impact factor: 3.404

Review 2.  The Hypothesis of the Prolonged Cell Cycle in Turner Syndrome.

Authors:  Francisco Álvarez-Nava; Marisol Soto-Quintana
Journal:  J Dev Biol       Date:  2022-05-11

Review 3.  Constitutional aneuploidy and cancer predisposition.

Authors:  Ithamar Ganmore; Gil Smooha; Shai Izraeli
Journal:  Hum Mol Genet       Date:  2009-04-15       Impact factor: 6.150

4.  Topical 2'-Hydroxyflavanone for Cutaneous Melanoma.

Authors:  Chhanda Bose; Sharda P Singh; Henry Igid; William C Green; Sharad S Singhal; Jihyun Lee; Philip T Palade; Aditya Rajan; Somedeb Ball; Vijay Tonk; Ashly Hindle; Michelle Tarbox; Sanjay Awasthi
Journal:  Cancers (Basel)       Date:  2019-10-14       Impact factor: 6.639

5.  Primary leiomyosarcoma of a horseshoe kidney in a woman with Turner syndrome: a case report.

Authors:  Toshikazu Tanaka; Takuya Koie; Ikuya Iwabuchi; Masaru Ogasawara; Toshiaki Kawaguchi; Chikara Ohyama
Journal:  BMC Res Notes       Date:  2014-08-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.